及时的联系:APOE4,衰老和阿尔茨海默病
1Department of Neuroscience, Department of Genetics, Hope Center for Neurological Disorders, Center for Brain Immunology and Glia, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Immunity
|January 10, 2024
概括
衰老和APOE4基因加速阿尔茨海默氏症 (AD) 通过在大脑微质中创造一种疲状态,特别是在具有APOE4基因变异的老年人中.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 晚期阿尔茨海默氏病 (AD) 受老化和阿波利波蛋白E4 (APOE4) 等位基因的影响.
- 这些因素推动AD进展的具体机制仍然不完全理解.
研究的目的:
- 在阿尔茨海默氏病模型中研究APOE基因型和衰老对微质状态的影响.
- 为了确定与AD风险因素相关的特定微质表型.
主要方法:
- 从AD小鼠模型中分析不同的APOE等位基因在不同年龄段的微质细胞.
- 微质状态的表征使用转录和细胞分析技术.
主要成果:
- 一个保存的,耗尽的微质状态被确定.
- 这种状态被发现在老年APOE4向的阿尔茨海默病小鼠大脑中得到了丰富.
- 这些发现表明,与AD风险相关的特定微质功能障碍.
结论:
- 衰老和APOE4等位基因因通过诱导有害的微质状态,有助于阿尔茨海默病的进展.
- 这种疲的微质表型代表了阿尔茨海默病的潜在治疗标.
相关概念视频
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
Aging
52
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
52
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


